Literature DB >> 1249185

Heterogeneity of plasma glucagon: patterns in patients with chronic renal failure and diabetes.

S F Kuku, A Zeidler, D S Emmanouel, A I Katz, A H Rubenstein.   

Abstract

Immunoreactive plasma glucagon (IRG) in normal subjects and patients with chronic renal failure, diabetic ketoacidosis and diagetic hyperosmolar syndrome circulates in several forms. In the diabetic patients most IRG eluted coincidentally with the extracted, purified pancreatic hormone (MW3500), while in normal subjects a high molecular weight component predominated. In striking contrast, the major component of plasma IRG in patients with chronic renal failure was of intermediate size (MW +/- 9000), consistent with proglucagon. The accumulation of this form of IRG suggests that the kidney plays an important role in its metabolism. If there are differences in the biological activity of the various circulating components of IRG, the significance of immunoreactive glucagon levels in some disease states will require reassessment.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1249185     DOI: 10.1210/jcem-42-1-173

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  23 in total

1.  Decreased glucagon receptors in diabetic rat hepatocytes. Evidence for regulation of glucagon receptors by hyperglucagonemia.

Authors:  S J Bhathena; N R Voyles; S Smith; L Recant
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

2.  Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.

Authors:  S F Kuku; J B Jaspan; D S Emmanouel; A Zeidler; A I Katz; A H Rubenstein
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

3.  From plant physiology to human metabolic investigations.

Authors:  P J Lefèbvre
Journal:  Diabetologia       Date:  1985-05       Impact factor: 10.122

4.  Effect of renal failure on gastrointestinal hormones.

Authors:  J Hansky
Journal:  World J Surg       Date:  1979-08-31       Impact factor: 3.352

5.  Glucagon-stimulable adenylyl cyclase in rat liver. Effects of chronic uremia and intermittent glucagon administration.

Authors:  R R Dighe; F J Rojas; L Birnbaumer; A J Garber
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

6.  Glucagon-stimulable adenylyl cyclase in rat liver. The impact of streptozotocin-induced diabetes mellitus.

Authors:  R R Dighe; F J Rojas; L Birnbaumer; A J Garber
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

7.  Effect of portasystemic venous shunt surgery on hyperglucagonaemia in cirrhosis: paired studies of pre- and post-shunted subjects.

Authors:  F J Dudley; F P Alford; D J Chisholm; D M Findlay
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

8.  Glucagon metabolism in the rat.

Authors:  D S Emmanouel; J B Jaspan; A H Rubenstein; A H Huen; E Fink; A I Katz
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

9.  Glucagon levels in normal and diabetic subjects: use of a specific immunoabsorbent for glucagon radioimmunoassay.

Authors:  F P Alford; S R Bloodm; J D Nabarro
Journal:  Diabetologia       Date:  1977-01       Impact factor: 10.122

10.  Prospective evaluation of some candidate tumor markers in the diagnosis of pancreatic cancer.

Authors:  C R Mackie; A R Moossa; V L Go; G Noble; G Sizemore; M J Cooper; R A Wood; A W Hall; T Waldmann; F Gelder; A H Rubenstein
Journal:  Dig Dis Sci       Date:  1980-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.